Selegiline reduces daytime sleepiness in patients with Parkinson's disease-Reference-Cited by-同舟云学术

Selegiline reduces daytime sleepiness in patients with Parkinson's disease

Published:2021-03-23 Issue:5 Volume:11 Page:
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain Behav

Author:

Gallazzi Marco¹,Mauri Marco¹²,Bianchi Maria Laura³,Riboldazzi Giulio⁴,Princiotta Cariddi Lucia¹²,Carimati Federico¹,Rebecchi Valentina¹,Versino Maurizio¹²^ORCID

Affiliation:

1. Neurologia e Stroke Unit ASST Sette Laghi Ospedale di Circolo di Varese Italy

2. Università dell’Insubria Varese Italy

3. Casa di Cura Fondazione Gaetano e Piera Borghi Brebbia Italy

4. Neurologia e Stroke Unit ASST Valle Olona Ospedale S. Antonio Abate Gallarate Italy

Publisher

Wiley

Subject

Behavioral Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.1880

Reference28 articles.

1. Excessive daytime sleepiness and subsequent development of Parkinson disease

2. Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study

3. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease

4. Current Nondopaminergic Therapeutic Options for Motor Symptoms of Parkinson's Disease

5. Modafinil for the Treatment of Daytime Sleepiness in Parkinson´s Disease: A Double-blind, Randomized, Crossover, Placebo-controlled Polygraphic Trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sleep disorders and Parkinson’s disease: is there a right direction?;Journal of Neurology;2024-08-12

2. Early Detection Of Parkinson’s Disease Using Machine And Deep Learning Models;2024 16th International Conference on Electronics, Computers and Artificial Intelligence (ECAI);2024-06-27

3. Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome;Movement Disorders Clinical Practice;2024-05-30

4. Motor and non-motor symptoms, drugs, and their mode of action in Parkinson’s disease (PD): a review;Medicinal Chemistry Research;2024-03-07

5. Risk Factors of Non-motor Symptoms in Different Stages of Parkinson’s Disease;2023-08-24